Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
01 1Zhejiang Hengkang Pharmaceutical
02 1Granules India Limited
03 1ChemWerth Inc
04 1Biophore India Pharmaceuticals Pvt Ltd
05 1Metrochem API Private Limited
06 1Nuray Chemicals Private Limited
07 1Aptra Synthesis
08 1HRV Global Life Sciences
09 1Chunghwa Chemical Synthesis & Biotech
10 1Amino Chemicals
11 1Aurobindo Pharma Limited
12 1Beijing Mesochem Technology
13 1Cambrex Corporation
14 1Cdymax
15 1Changzhou Pharmaceutical Factory
16 1Deva Holding AS
17 1Erregierre SpA
18 1Extrovis AG
19 1Fujian South Pharmaceutical
20 2Guangdong Raffles PharmaTech Co Ltd
21 1Hangzhou Longshine Bio-Tech
22 1Hetero Drugs
23 1Kimia Biosciences
24 1Lee Pharma
25 2MSN Laboratories
26 1Optimus Pharma
27 1Quimica Sintetica
28 1Raks Pharma
29 1Shanvr Life Sciences
30 1Shenzhen Haorui
31 1Shenzhen HwaGen Pharmaceutical
32 1Shilpa Medicare
33 1Synthimed Labs
34 1Teva API
35 2Teva Pharmaceutical Industries
36 1Waterstone Pharmaceuticals Inc.
37 1Zhejiang Multinpharma
38 1Zydus Lifesciences
01 11China
02 19India
03 3Israel
04 1Italy
05 1Malta
06 1Spain
07 1Switzerland
08 1Taiwan
09 1Turkey
10 2U.S.A
01 18Active
02 23Blank
01 41Blank
01 41Blank
01 1WC-0021
02 1WC-0021n
03 1WC-0040
04 1WC-0517
05 1WC-0526
06 36Blank
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-02-13
Pay. Date : 2024-01-08
DMF Number : 39129
Submission : 2023-12-31
Status : Active
Type : II
Date of Issue : 2022-05-02
Valid Till : 2025-05-01
Written Confirmation Number : WC-0526
Address of the Firm :
NDC Package Code : 62207-971
Start Marketing Date : 2021-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, ROW, CA, BR |
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-10-25
Pay. Date : 2022-09-28
DMF Number : 37269
Submission : 2022-08-29
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-08
Pay. Date : 2023-09-28
DMF Number : 38008
Submission : 2023-03-31
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-067
Start Marketing Date : 2024-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6274
Start Marketing Date : 2022-10-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-06-01
Pay. Date : 2017-04-21
DMF Number : 31667
Submission : 2017-04-29
Status : Active
Type : II
Date of Issue : 2022-02-01
Valid Till : 2025-01-31
Written Confirmation Number : WC-0517
Address of the Firm :
NDC Package Code : 47621-307
Start Marketing Date : 2017-06-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 38 companies offering Eltrombopag
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?